CA Patent

CA2809911A1 — Bicyclic aza heterocycles, and use thereof

Assigned to Bayer Intellectual Property GmbH · Expires 2012-03-08 · 14y expired

What this patent protects

The application relates to novel bicyclic aza heterocycles, methods for the production thereof, the use thereof on their own or in combinations for the treatment and/or prevention of diseases, and the use thereof for the production of medicaments used for treating and/or preventi…

USPTO Abstract

The application relates to novel bicyclic aza heterocycles, methods for the production thereof, the use thereof on their own or in combinations for the treatment and/or prevention of diseases, and the use thereof for the production of medicaments used for treating and/or preventing diseases, in particular cardiovascular diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2809911A1
Jurisdiction
CA
Classification
—
Expires
2012-03-08
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Intellectual Property GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.